Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3-Vessel and Left Main Coronary Artery Disease: A Population-Based Cohort Study

被引:0
|
作者
Wilson, Todd [1 ,2 ,4 ]
James, Matthew T. [1 ,2 ,4 ]
Southern, Danielle [6 ]
Har, Bryan [3 ,4 ]
Graham, Michelle M. [5 ]
Brass, Neil [7 ]
Bainey, Kevin [5 ]
Fedak, Paul W. M. [3 ,4 ]
Sajobi, Tolulope T. [2 ,4 ]
Wilton, Stephen B. [2 ,3 ,4 ]
机构
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada
[4] Univ Calgary, CanadaLibin Cardiovasc Inst, Calgary, AB, Canada
[5] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada
[6] Univ Calgary, Ctr Hlth Informat, Cumming Sch Med, Calgary, AB, Canada
[7] Univ Alberta, CKHui Heart Ctr, Edmonton, AB, Canada
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2024年 / 13卷 / 18期
关键词
coronary artery disease; death; practice variation; revascularization; NEW-YORK-STATE; SURGERY; INTERVENTION; VALIDATION;
D O I
10.1161/JAHA.123.035356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hospital- and physician-level variation for selection of percutaneous coronary intervention versus coronary artery bypass grafting (CABG) for patients with coronary artery disease has been associated with outcome differences. However, most studies excluded patients treated medically.Methods and Results From 2010 to 2019, adults with 3-vessel or left main coronary artery disease at 3 hospitals (A, B, C) in Alberta, Canada, were categorized by treatment with medical therapy, percutaneous coronary intervention, or CABG. Multilevel regression models determined the proportion of variation in treatment attributable to patient, physician, and hospital factors, and survival models assessed outcomes including death and major adverse cardiovascular events over 5 years. Of 22 580 patients (mean age, 67 years; 80% men): 6677 (29%) received medical management, 9171 (41%) percutaneous coronary intervention, and 6732 (30%) CABG. Hospital factors accounted for 10.8% of treatment variation. In adjusted models (site A as reference), patients at sites B and C had 49% (95% CI, 44%-53%) and 43% (95% CI, 37%-49%) lower rates of medical therapy, respectively, and 31% (95% CI, 24%-38%) and 32% (95% CI, 24%-40%) lower rates of CABG. During 5.0 years median follow-up, 3287 (14.6%) patients died, with no intersite mortality differences. There were no between-site differences in acute coronary syndromes or stroke; patients at sites B and C had 24% lower risk (95% CI, 13%-34% and 11%-35%, respectively) of heart failure hospitalization.Conclusions Hospital-level variation in selection of percutaneous coronary intervention, CABG, or medical therapy for patients with complex coronary artery disease was not associated with differences in 5-year mortality rates. Research and quality improvement initiatives comparing revascularization practices should include medically managed patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Long-term Outcomes of Dialysis Patients After Coronary Revascularization: A Population-based Cohort Study in Taiwan
    Chou, Chu-lin
    Hsieh, Tsung-cheng
    Wang, Chih-hsien
    Hung, Tsung-hsing
    Lai, Yu-hsien
    Chen, Yi-ya
    Lin, Yu-li
    Kuo, Chiu-huang
    Wu, Ya-ju
    Fang, Te-chao
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (02) : 188 - 194
  • [12] Outcomes of Myocardial Revascularization in Diabetic Patients With Left Main Coronary Artery Disease: A Multicenter Observational Study From Three Gulf Countries
    Daoulah, Amin
    Elfarnawany, Amr
    Al Garni, Turki
    Hersi, Ahmad S.
    Alshehri, Mohammed
    Almahmeed, Wael
    Yousif, Nooraldaem
    Abuelatta, Reda
    Alasmari, Abdulaziz
    Elsheikh-Mohamed, Nezar Essam
    Alzahrani, Badr
    Ghani, Mohamed Ajaz
    Amin, Haitham
    Hashmani, Shahrukh
    Hiremath, Niranjan
    Alshali, Khalid Z.
    Elmahrouk, Youssef
    Kazim, Hameedullah M.
    Refaat, Wael
    Selim, Ehab
    Jamjoom, Ahmed
    Feteih, Maun N.
    El-Sayed, Osama
    Al-Faifi, Salem M.
    Dahdouh, Ziad
    Aithal, Jairam
    Ibrahim, Ahmed M.
    Elganady, Abdelmaksoud
    Qutub, Mohammed A.
    Alama, Mohamed N.
    Abohasan, Abdulwali
    Hassan, Taher
    Balghith, Mohammed
    Hussien, Adnan Fathey
    Abdulhabeeb, Ibrahim A. M.
    Ahmad, Osama
    Ramadan, Mohamed
    Alqahtani, Abdulrahman H.
    Abumelha, Bader K.
    Qenawi, Wael
    Shawky, Ahmed
    Ghonim, Ahmed A.
    Elmahrouk, Ahmed
    Alhamid, Sameer
    Maghrabi, Mohamed
    Haddara, Mamdouh M.
    Aljohar, Alwaleed
    Hurley, William T.
    Alshahrani, Saif S.
    Lotfi, Amir
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 46 : 52 - 61
  • [13] Celiac Disease Patients With Coronary Artery Disease: A Nationwide Population-Based Study
    Haider, Maryam B.
    Naylor, Paul
    Das, Avijit
    Haider, Syed M.
    Ehrinpreis, Murray N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [14] Outcomes Among Coronary Artery Disease Patients Hospitalized for Left Ventricular Assist Device Implantation: A United States Population- Based Cohort Study
    Casipit, Bruce Adrian
    Idowu, Abiodun
    Al Sudani, Hussein
    Casipit, Carlo
    Lo, Kevin Bryan
    Khraisha, Ola
    Amanullah, Aman M.
    CIRCULATION, 2023, 148
  • [15] EFFECT OF COMPLETENESS OF REVASCULARIZATION ON LONG-TERM OUTCOME OF PATIENTS WITH 3-VESSEL DISEASE UNDERGOING CORONARY-ARTERY BYPASS-SURGERY - A REPORT FROM THE CORONARY-ARTERY SURGERY STUDY (CASS) REGISTRY
    BELL, MR
    GERSH, BJ
    SCHAFF, HV
    HOLMES, DR
    FISHER, LD
    ALDERMAN, EL
    MYERS, WO
    PARSONS, LS
    REEDER, GS
    CIRCULATION, 1992, 86 (02) : 446 - 457
  • [16] 5-Year Quality of Life Outcomes After CABG vs. PCI among Patients With 3-Vessel or Left Main Coronary Disease: Results From the SYNTAX Trial
    Abdallah, Mouin S.
    Cohen, David J.
    Wang, Kaijun
    Magnuson, Elizabeth A.
    Osnabrugge, Ruben L.
    Kappetein, A. P.
    Morice, Marie-Claude
    Mohr, Friedrich A.
    Serruys, Patrick W.
    CIRCULATION, 2013, 128 (22)
  • [17] The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥40%: A Population-Based Cohort Study (Nebivolol-TR Study)
    Altin, Cihan
    Okyay, Kaan
    Kis, Mehmet
    Eren, Hayati
    Bekar, Lutfi
    Dogan, Yasemin
    Aydin, Gokhan
    Guzel, Tuncay
    Harbalioglu, Hazar
    Tanik, Veysel Ozan
    Cersit, Sinan
    Karaaslan, Ozge Cakmak
    Cekici, Yusuf
    Boyuk, Ferit
    Coner, Ali
    Kocaba, Umut
    Yenercag, Mustafa
    Caliskan, Serhat
    Er, Fahri
    Sinan, Umit Yasar
    Ulus, Taner
    Gul, Sefa
    Oz, Ahmet
    Candemir, Alper
    Cetinarslan, Ozge
    Yuce, Elif Ilkay
    Tanriverdi, Zulkif
    Tascanov, Mustafa Begenc
    Yeni, Mehtap
    Ozbay, Benay
    Ozturk, Onder
    Bedir, Omer
    Yilmaz, Mehmet Mustafa
    Tekindal, Mustafa Agah
    Zoghi, Mehdi
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (08): : 568 - 575
  • [18] Outcomes following surgical revascularization with single versus bilateral internal thoracic arterial grafts in patients with left main coronary artery disease undergoing coronary artery bypass grafting: insights from the EXCEL trial
    Thuijs, Daniel J. F. M.
    Head, Stuart J.
    Stone, Gregg W.
    Puskas, John D.
    Taggart, David P.
    Serruys, Patrick W.
    Dressler, Ovidiu
    Crowley, Aaron
    Brown, W. Morris, III
    Horkay, Ferenc
    Boonstra, Piet W.
    Bogats, Gabor
    Noiseux, Nicolas
    Sabik, Joseph F., III
    Kappetein, A. Pieter
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2019, 55 (03) : 501 - 509
  • [19] Mild renal function impairment and long-term outcomes in patients with three-vessel coronary artery disease: a cohort study
    Zeng, Guyu
    Yuan, Deshan
    Wang, Peizhi
    Li, Tianyu
    Jiang, Lin
    Xu, Lianjun
    Tian, Jian
    Zhao, Xueyan
    Feng, Xinxing
    Wang, Dong
    Zhang, Yin
    Sun, Kai
    Xu, Jingjing
    Liu, Ru
    Xu, Bo
    Zhao, Wei
    Hui, Rutai
    Gao, Runlin
    Song, Lei
    Yuan, Jinqing
    CARDIORENAL MEDICINE, 2023, 13 (01) : 354 - 362
  • [20] Patients with 3-Vessel Coronary Artery Disease and Impaired Ventricular Function Undergoing PCI with Impella 2.5 Hemodynamic Support Have Improved 90-Day Outcomes Compared to Intra-Aortic Balloon Pump: A Sub-Study of The PROTECT II Trial
    Kovacic, Jason C.
    Kini, Annapoorna
    Banerjee, Subhash
    Dangas, George
    Massaro, Joseph
    Mehran, Roxana
    Popma, Jeffrey
    O'neill, William W.
    Sharma, Samin K.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2015, 28 (01) : 32 - 40